GeoVax HIV Clinical Trials Update
ATLANTA, GA--(Marketwired - Nov 15, 2017) - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced that the HIV Vaccine Trials Network (HVTN) has closed enrollment for the phase 1 human clinical trial evaluating …